Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
出版年份 2017 全文链接
标题
Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
作者
关键词
-
出版物
Frontiers in Molecular Neuroscience
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-12-07
DOI
10.3389/fnmol.2017.00405
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy
- (2017) N N Singh et al. GENE THERAPY
- Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1G93A ALS rat but has adverse side effects
- (2017) G M Thomsen et al. GENE THERAPY
- Developmental regulation of SMN expression: pathophysiological implications and perspectives for therapy development in spinal muscular atrophy
- (2017) S Jablonka et al. GENE THERAPY
- Therapeutic approaches for spinal muscular atrophy (SMA)
- (2017) M Scoto et al. GENE THERAPY
- Linking amyotrophic lateral sclerosis and spinal muscular atrophy through RNA-transcriptome homeostasis: a genomics perspective
- (2017) Margarida Gama-Carvalho et al. JOURNAL OF NEUROCHEMISTRY
- A multi-source approach to determine SMA incidence and research ready population
- (2017) Ingrid E. C. Verhaart et al. JOURNAL OF NEUROLOGY
- Edaravone: a new treatment for ALS on the horizon?
- (2017) Orla Hardiman et al. LANCET NEUROLOGY
- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2017) Koji Abe et al. LANCET NEUROLOGY
- A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model
- (2017) Maria Grazia Biferi et al. MOLECULAR THERAPY
- Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
- (2017) Lindsay A. Becker et al. NATURE
- Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems
- (2017) Ken Y Chan et al. NATURE NEUROSCIENCE
- Spinal muscular atrophy: Factors that modulate motor neurone vulnerability
- (2017) Wen-Yo Tu et al. NEUROBIOLOGY OF DISEASE
- Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next?
- (2017) Raymond T. Bartus et al. NEUROBIOLOGY OF DISEASE
- Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned?
- (2017) Raymond T. Bartus et al. NEUROBIOLOGY OF DISEASE
- Urinary p75 ECD
- (2017) Stephanie R. Shepheard et al. NEUROLOGY
- Spinal muscular atrophy: A changing phenotype beyond the clinical trials
- (2017) Eduardo F. Tizzano et al. NEUROMUSCULAR DISORDERS
- The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy
- (2017) Constantin d’Ydewalle et al. NEURON
- TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics
- (2017) Ian R. Mackenzie et al. NEURON
- Slow Intrathecal Injection of rAAVrh10 Enhances its Transduction of Spinal Cord and Therapeutic Efficacy in a Mutant SOD1 Model of ALS
- (2017) Dongxiao Li et al. NEUROSCIENCE
- The Actin Cytoskeleton in SMA and ALS: How Does It Contribute to Motoneuron Degeneration?
- (2017) Niko Hensel et al. NEUROSCIENTIST
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amyotrophic Lateral Sclerosis
- (2017) Robert H. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review
- (2017) Ingrid E. C. Verhaart et al. Orphanet Journal of Rare Diseases
- Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy
- (2017) Caroline J. Woo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy
- (2017) Fazel Shabanpoor et al. Nucleic Acid Therapeutics
- Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice
- (2017) Alessia Mirra et al. Scientific Reports
- Single-Cell Analysis of SMN Reveals Its Broader Role in Neuromuscular Disease
- (2017) Natalia Rodriguez-Muela et al. Cell Reports
- ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
- (2017) Dmitry Petrov et al. Frontiers in Aging Neuroscience
- The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison
- (2017) Sarah Martin et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Open label study to assess the safety of VM202 in subjects with amyotrophic lateral sclerosis
- (2017) Robert L. Sufit et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- The Enigmatic Role of C9ORF72 in Autophagy
- (2017) Melissa Nassif et al. Frontiers in Neuroscience
- Improving the Delivery of SOD1 Antisense Oligonucleotides to Motor Neurons Using Calcium Phosphate-Lipid Nanoparticles
- (2017) Liyu Chen et al. Frontiers in Neuroscience
- Viral Vector-Mediated Antisense Therapy for Genetic Diseases
- (2017) Marine Imbert et al. Genes
- Additive amelioration of ALS by co-targeting independent pathogenic mechanisms
- (2017) Ashley E. Frakes et al. Annals of Clinical and Translational Neurology
- TIA1 is a gender-specific disease modifier of a mild mouse model of spinal muscular atrophy
- (2017) Matthew D. Howell et al. Scientific Reports
- The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype
- (2016) Seyyedmohsen Hosseinibarkooie et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Vascular Defects and Spinal Cord Hypoxia in Spinal Muscular Atrophy
- (2016) Eilidh Somers et al. ANNALS OF NEUROLOGY
- Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model
- (2016) Lorelei Stoica et al. ANNALS OF NEUROLOGY
- NEK1mutations in familial amyotrophic lateral sclerosis
- (2016) David Brenner et al. BRAIN
- Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers
- (2016) Fabiola Puentes et al. BRAIN PATHOLOGY
- scAAV9-VEGF prolongs the survival of transgenic ALS mice by promoting activation of M2 microglia and the PI3K/Akt pathway
- (2016) Ying Wang et al. BRAIN RESEARCH
- Minor intron splicing is regulated by FUS and affected by ALS‐associated FUS mutants
- (2016) Stefan Reber et al. EMBO JOURNAL
- Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss
- (2016) Jelena Scekic‐Zahirovic et al. EMBO JOURNAL
- Therapeutic rAAVrh10 MediatedSOD1Silencing in AdultSOD1G93AMice and Nonhuman Primates
- (2016) Florie Borel et al. HUMAN GENE THERAPY
- Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset
- (2016) Zhihua Feng et al. HUMAN MOLECULAR GENETICS
- Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice
- (2016) Nirma D. Perera et al. HUMAN MOLECULAR GENETICS
- Defective control of pre–messenger RNA splicing in human disease
- (2016) Benoit Chabot et al. JOURNAL OF CELL BIOLOGY
- Intrathecal Injections in Children With Spinal Muscular Atrophy
- (2016) Manon Haché et al. JOURNAL OF CHILD NEUROLOGY
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- (2016) Richard S Finkel et al. LANCET
- Intramuscular Delivery of scAAV9-hIGF1 Prolongs Survival in the hSOD1G93A ALS Mouse Model via Upregulation of D-Amino Acid Oxidase
- (2016) HuiQian Lin et al. MOLECULAR NEUROBIOLOGY
- C9ORF72 Regulates Stress Granule Formation and Its Deficiency Impairs Stress Granule Assembly, Hypersensitizing Cells to Stress
- (2016) Niran Maharjan et al. MOLECULAR NEUROBIOLOGY
- Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 Splicing
- (2016) Philipp Odermatt et al. MOLECULAR THERAPY
- Decoding ALS: from genes to mechanism
- (2016) J. Paul Taylor et al. NATURE
- Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
- (2016) Benjamin E Deverman et al. NATURE BIOTECHNOLOGY
- Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
- (2016) Wouter van Rheenen et al. NATURE GENETICS
- Neuregulin-1 promotes functional improvement by enhancing collateral sprouting in SOD1G93A ALS mice and after partial muscle denervation
- (2016) Renzo Mancuso et al. NEUROBIOLOGY OF DISEASE
- Intrathecal Delivery of ssAAV9-DAO Extends Survival in SOD1G93A ALS Mice
- (2016) Wan Wang et al. NEUROCHEMICAL RESEARCH
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs
- (2016) Jie Jiang et al. NEURON
- Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
- (2016) Suzan M. Hammond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS
- (2016) Ilary Allodi et al. Scientific Reports
- Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS
- (2016) Patrick Oeckl et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains
- (2016) Erin G Conlon et al. eLife
- αCAR IGF-1 vector targeting of motor neurons ameliorates disease progression in ALS mice
- (2016) Ioanna Eleftheriadou et al. Annals of Clinical and Translational Neurology
- Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
- (2016) M. Nizzardo et al. Scientific Reports
- Targeting Motor End Plates for Delivery of Adenoviruses: An Approach to Maximize Uptake and Transduction of Spinal Cord Motor Neurons
- (2016) Andrew Paul Tosolini et al. Scientific Reports
- Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis
- (2016) Matthew J. Fogarty et al. Scientific Reports
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- Antisense oligonucleotides in therapy for neurodegenerative disorders
- (2015) Melvin M. Evers et al. ADVANCED DRUG DELIVERY REVIEWS
- Improvement of SMN2 Pre-mRNA Processing Mediated by Exon-Specific U1 Small Nuclear RNA
- (2015) Andrea Dal Mas et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A large animal model of spinal muscular atrophy and correction of phenotype
- (2015) Sandra I. Duque et al. ANNALS OF NEUROLOGY
- Current developments in gene therapy for amyotrophic lateral sclerosis
- (2015) Joseph M Scarrott et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models
- (2015) Yimin Hua et al. GENES & DEVELOPMENT
- Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response
- (2015) Haiyan Zhou et al. HUMAN MOLECULAR GENETICS
- Multifactorial Gene Therapy Enhancing the Glutamate Uptake System and Reducing Oxidative Stress Delays Symptom Onset and Prolongs Survival in the SOD1-G93A ALS Mouse Model
- (2015) Chen Benkler et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Disease Mechanisms and Therapeutic Approaches in Spinal Muscular Atrophy
- (2015) S. Tisdale et al. JOURNAL OF NEUROSCIENCE
- Motor Cortex Layer V Pyramidal Neurons Exhibit Dendritic Regression, Spine Loss, and Increased Synaptic Excitation in the Presymptomatic hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
- (2015) M. J. Fogarty et al. JOURNAL OF NEUROSCIENCE
- Widespread and Efficient Transduction of Spinal Cord and Brain Following Neonatal AAV Injection and Potential Disease Modifying Effect in ALS Mice
- (2015) Jacob I Ayers et al. MOLECULAR THERAPY
- Improving Single Injection CSF Delivery of AAV9-mediated Gene Therapy for SMA: A Dose–response Study in Mice and Nonhuman Primates
- (2015) Kathrin Meyer et al. MOLECULAR THERAPY
- Genetic compensation induced by deleterious mutations but not gene knockdowns
- (2015) Andrea Rossi et al. NATURE
- Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
- (2015) Axel Freischmidt et al. NATURE NEUROSCIENCE
- Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
- (2015) C.-H. Lu et al. NEUROLOGY
- The effect of the DcpS inhibitor D156844 on the protective action of follistatin in mice with spinal muscular atrophy
- (2015) Ashlee W. Harris et al. NEUROMUSCULAR DISORDERS
- Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease
- (2015) Jeffrey Rosenfeld et al. Neurotherapeutics
- U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish
- (2015) Yong Yu et al. NUCLEIC ACIDS RESEARCH
- Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II/III spinal muscular atrophy
- (2015) Laurent P. Bogdanik et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
- (2015) E. T. Cirulli et al. SCIENCE
- ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP
- (2015) Shuying Sun et al. Nature Communications
- Effect of Combined Systemic and Local Morpholino Treatment on the Spinal Muscular Atrophy Δ7 Mouse Model Phenotype
- (2014) Monica Nizzardo et al. CLINICAL THERAPEUTICS
- Gem Depletion: Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy Crossover
- (2014) Ruben J. Cauchi CNS Neuroscience & Therapeutics
- Fishing for causes and cures of motor neuron disorders
- (2014) S. A. Patten et al. Disease Models & Mechanisms
- The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice
- (2014) Matthew E.R. Butchbach et al. EXPERIMENTAL NEUROLOGY
- Gene Therapy: A Promising Approach to Treating Spinal Muscular Atrophy
- (2014) Pádraig J. Mulcahy et al. HUMAN GENE THERAPY
- Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models
- (2014) Erkan Y. Osman et al. HUMAN MOLECULAR GENETICS
- Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation
- (2014) Shingo Kariya et al. JOURNAL OF CLINICAL INVESTIGATION
- Transplanted Modified Muscle Progenitor Cells Expressing a Mixture of Neurotrophic Factors Delay Disease Onset and Enhance Survival in the SOD1 Mouse Model of ALS
- (2014) M. Dadon-Nachum et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Delayed Disease Onset and Extended Survival in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis after Suppression of Mutant SOD1 in the Motor Cortex
- (2014) G. M. Thomsen et al. JOURNAL OF NEUROSCIENCE
- SMN1 duplications contribute to sporadic amyotrophic lateral sclerosis susceptibility: Evidence from a meta-analysis
- (2014) Xue-Bin Wang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Advances in motor neurone disease
- (2014) Dirk Bäumer et al. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
- Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
- (2014) Hiroshi Mitsumoto et al. LANCET NEUROLOGY
- Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study
- (2014) Ammar Al-Chalabi et al. LANCET NEUROLOGY
- Adeno-associated Virus–mediated Delivery of a Recombinant Single-chain Antibody Against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis
- (2014) Priyanka Patel et al. MOLECULAR THERAPY
- Targeting the motor end plates in the mouse hindlimb gives access to a greater number of spinal cord motor neurons: An approach to maximize retrograde transport
- (2014) R. Mohan et al. NEUROSCIENCE
- SOD1 Function and Its Implications for Amyotrophic Lateral Sclerosis Pathology
- (2014) Rosie K. A. Bunton-Stasyshyn et al. NEUROSCIENTIST
- Nuclear localization of SMN and FUS is not altered in fibroblasts from patients with sporadic ALS
- (2014) Shingo Kariya et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
- (2014) Koji Abe et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Biology of adeno-associated viral vectors in the central nervous system
- (2014) Giridhar Murlidharan et al. Frontiers in Molecular Neuroscience
- ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease
- (2014) Elizabeth B. Moloney et al. Frontiers in Neuroscience
- A Short Antisense Oligonucleotide Ameliorates Symptoms of Severe Mouse Models of Spinal Muscular Atrophy
- (2014) Jeffrey M Keil et al. Molecular Therapy-Nucleic Acids
- hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations
- (2013) Kohji Mori et al. ACTA NEUROPATHOLOGICA
- Sodium vanadate combined with l-ascorbic acid delays disease progression, enhances motor performance, and ameliorates muscle atrophy and weakness in mice with spinal muscular atrophy
- (2013) Huei-Chun Liu et al. BMC Medicine
- Is SOD1 loss of function involved in amyotrophic lateral sclerosis?
- (2013) Rachele A. Saccon et al. BRAIN
- Moving forward in clinical trials for ALS: motor neurons lead the way please
- (2013) Barış Genç et al. DRUG DISCOVERY TODAY
- scAAV9 Intracisternal Delivery Results in Efficient Gene Transfer to the Central Nervous System of a Feline Model of Motor Neuron Disease
- (2013) Thomas Bucher et al. HUMAN GENE THERAPY
- Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis
- (2013) Tomohiko Ishihara et al. HUMAN MOLECULAR GENETICS
- Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy
- (2013) James N. Sleigh et al. HUMAN MOLECULAR GENETICS
- ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN
- (2013) Ewout J.N. Groen et al. HUMAN MOLECULAR GENETICS
- Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis
- (2013) Hongyan Wang et al. HUMAN MOLECULAR GENETICS
- Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice
- (2013) Erica D. Koval et al. HUMAN MOLECULAR GENETICS
- An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
- (2013) Timothy M Miller et al. LANCET NEUROLOGY
- Controversies and priorities in amyotrophic lateral sclerosis
- (2013) Martin R Turner et al. LANCET NEUROLOGY
- Synergistic Effects of GDNF and VEGF on Lifespan and Disease Progression in a Familial ALS Rat Model
- (2013) Dan Krakora et al. MOLECULAR THERAPY
- Therapeutic AAV9-mediated Suppression of Mutant SOD1 Slows Disease Progression and Extends Survival in Models of Inherited ALS
- (2013) Kevin D Foust et al. MOLECULAR THERAPY
- Viral Delivery of Antioxidant Genes as a Therapeutic Strategy in Experimental Models of Amyotrophic Lateral Sclerosis
- (2013) Aikaterini Nanou et al. MOLECULAR THERAPY
- Dual Masking of Specific Negative Splicing Regulatory Elements Resulted in Maximal Exon 7 Inclusion of SMN2 Gene
- (2013) Peng Wen Pao et al. MOLECULAR THERAPY
- Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis
- (2013) Shin H Kang et al. NATURE NEUROSCIENCE
- State of play in amyotrophic lateral sclerosis genetics
- (2013) Alan E Renton et al. NATURE NEUROSCIENCE
- The epidemiology of ALS: a conspiracy of genes, environment and time
- (2013) Ammar Al-Chalabi et al. Nature Reviews Neurology
- Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice
- (2013) Bradley J. Turner et al. NEUROBIOLOGY OF AGING
- Mislocalised FUS mutants stall spliceosomal snRNPs in the cytoplasm
- (2013) Valeria Gerbino et al. NEUROBIOLOGY OF DISEASE
- Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
- (2013) Shuo-Chien Ling et al. NEURON
- Spinal inhibitory circuits and their role in motor neuron degeneration
- (2013) Uri Nimrod Ramírez-Jarquín et al. NEUROPHARMACOLOGY
- Glial Promoter Selectivity following AAV-Delivery to the Immature Brain
- (2013) Georg von Jonquieres et al. PLoS One
- Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy
- (2013) Z. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hexanucleotide Repeats in ALS/FTD Form Length-Dependent RNA Foci, Sequester RNA Binding Proteins, and Are Neurotoxic
- (2013) Youn-Bok Lee et al. Cell Reports
- Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice
- (2013) Gotkine Marc et al. Biomed Research International
- Targeting the Full Length of the Motor End Plate Regions in the Mouse Forelimb Increases the Uptake of Fluoro-Gold into Corresponding Spinal Cord Motor Neurons
- (2013) Andrew Paul Tosolini et al. Frontiers in Neurology
- Spliceosome integrity is defective in the motor neuron diseases ALS and SMA
- (2012) Hitomi Tsuiji et al. EMBO Molecular Medicine
- Homozygous SMN2 deletion is a protective factor in the Swedish ALS population
- (2012) Philippe Corcia et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Cell-penetrating peptides for the delivery of nucleic acids
- (2012) Taavi Lehto et al. Expert Opinion on Drug Delivery
- Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies
- (2012) Shingo Kariya et al. HUMAN MOLECULAR GENETICS
- Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality
- (2012) Bastian Ackermann et al. HUMAN MOLECULAR GENETICS
- Early pathogenesis in the adult-onset neurodegenerative disease amyotrophic lateral sclerosis
- (2012) Brigitte van Zundert et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Absence of consensus in diagnostic criteria for familial neurodegenerative diseases
- (2012) Susan Byrne et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Nuclear Localization of Human SOD1 and Mutant SOD1-Specific Disruption of Survival Motor Neuron Protein Complex in Transgenic Amyotrophic Lateral Sclerosis Mice
- (2012) Barry Gertz et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Motor Neuron Rescue in Spinal Muscular Atrophy Mice Demonstrates That Sensory-Motor Defects Are a Consequence, Not a Cause, of Motor Neuron Dysfunction
- (2012) R. G. Gogliotti et al. JOURNAL OF NEUROSCIENCE
- Survival Motor Neuron Protein in Motor Neurons Determines Synaptic Integrity in Spinal Muscular Atrophy
- (2012) T. L. Martinez et al. JOURNAL OF NEUROSCIENCE
- Pathophysiological Insights Derived by Natural History and Motor Function of Spinal Muscular Atrophy
- (2012) Michelle A. Farrar et al. JOURNAL OF PEDIATRICS
- Sialic Acid Deposition Impairs the Utility of AAV9, but Not Peptide-modified AAVs for Brain Gene Therapy in a Mouse Model of Lysosomal Storage Disease
- (2012) Yong Hong Chen et al. MOLECULAR THERAPY
- SMN1 gene duplications are associated with sporadic ALS
- (2012) H. M. Blauw et al. NEUROLOGY
- Spinal muscular atrophy at the crossroads of basic science and therapy
- (2012) James N. Sleigh et al. NEUROMUSCULAR DISORDERS
- Spinal muscular atrophy: going beyond the motor neuron
- (2012) Gillian Hamilton et al. TRENDS IN MOLECULAR MEDICINE
- FUS-SMN Protein Interactions Link the Motor Neuron Diseases ALS and SMA
- (2012) Tomohiro Yamazaki et al. Cell Reports
- SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
- (2012) Leah Winer et al. JAMA Neurology
- p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS
- (2011) Safa Al-Sarraj et al. ACTA NEUROPATHOLOGICA
- Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of Spinal Muscular Atrophy
- (2011) Jacqueline J. Glascock et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Invertebrate models of spinal muscular atrophy: Insights into mechanisms and potential therapeutics
- (2011) Stuart J. Grice et al. BIOESSAYS
- Familial versus sporadic amyotrophic lateral sclerosis--a false dichotomy?
- (2011) K. Talbot BRAIN
- Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis
- (2011) Monica Nizzardo et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
- (2011) J. N. Sleigh et al. Disease Models & Mechanisms
- Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs
- (2011) T Federici et al. GENE THERAPY
- Decreasing Disease Severity in Symptomatic, Smn−/−;SMN2+/+, Spinal Muscular Atrophy Mice Following scAAV9-SMN Delivery
- (2011) Jacqueline J. Glascock et al. HUMAN GENE THERAPY
- Adeno-Associated Virus Serotype 9 Transduction in the Central Nervous System of Nonhuman Primates
- (2011) Lluis Samaranch et al. HUMAN GENE THERAPY
- Increasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in mice
- (2011) Deborah Y. Kwon et al. HUMAN MOLECULAR GENETICS
- Temporal requirement for high SMN expression in SMA mice
- (2011) T. T. Le et al. HUMAN MOLECULAR GENETICS
- A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
- (2011) Paul N. Porensky et al. HUMAN MOLECULAR GENETICS
- Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy
- (2011) Cathleen M. Lutz et al. JOURNAL OF CLINICAL INVESTIGATION
- Amyotrophic lateral sclerosis
- (2011) Matthew C Kiernan et al. LANCET
- Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders
- (2011) Adam K Bevan et al. MOLECULAR THERAPY
- Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
- (2011) Yimin Hua et al. NATURE
- Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
- (2011) Magdalini Polymenidou et al. NATURE NEUROSCIENCE
- Clinical diagnosis and management of amyotrophic lateral sclerosis
- (2011) Orla Hardiman et al. Nature Reviews Neurology
- Gene therapy for amyotrophic lateral sclerosis
- (2011) Thais Federici et al. NEUROBIOLOGY OF DISEASE
- IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice
- (2011) Li-Kai Tsai et al. NEUROBIOLOGY OF DISEASE
- Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy
- (2011) Hansjörg Rindt et al. NEUROMUSCULAR DISORDERS
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
- (2011) Mariely DeJesus-Hernandez et al. NEURON
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
- (2011) Alan E. Renton et al. NEURON
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- Guidelines for preclinical animal research in ALS/MND: A consensus meeting
- (2010) Albert C. Ludolph et al. Amyotrophic Lateral Sclerosis
- A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade?
- (2010) Mark C. Bellingham CNS Neuroscience & Therapeutics
- The role of RNA processing in the pathogenesis of motor neuron degeneration
- (2010) Dirk Bäumer et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
- (2010) Y. Hua et al. GENES & DEVELOPMENT
- Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
- (2010) Elisa Dominguez et al. HUMAN MOLECULAR GENETICS
- CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy
- (2010) Marco A. Passini et al. JOURNAL OF CLINICAL INVESTIGATION
- An estimate of amyotrophic lateral sclerosis heritability using twin data
- (2010) A. Al-Chalabi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- TIA1 Prevents Skipping of a Critical Exon Associated with Spinal Muscular Atrophy
- (2010) N. N. Singh et al. MOLECULAR AND CELLULAR BIOLOGY
- AAV4-mediated Expression of IGF-1 and VEGF Within Cellular Components of the Ventricular System Improves Survival Outcome in Familial ALS Mice
- (2010) James C Dodge et al. MOLECULAR THERAPY
- Neuroprotection by Gene Therapy Targeting Mutant SOD1 in Individual Pools of Motor Neurons Does not Translate Into Therapeutic Benefit in fALS Mice
- (2010) Chris Towne et al. MOLECULAR THERAPY
- CNS-targeted Viral Delivery of G-CSF in an Animal Model for ALS: Improved Efficacy and Preservation of the Neuromuscular Unit
- (2010) Alexandre Henriques et al. MOLECULAR THERAPY
- Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
- (2010) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS
- (2010) Daryl A Bosco et al. NATURE NEUROSCIENCE
- Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice
- (2010) X. Shan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy
- (2010) C. F. Valori et al. Science Translational Medicine
- Treatment strategies for spinal muscular atrophy
- (2010) Heidi Fuller et al. Translational Neuroscience
- Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand ?
- (2010) Henriques Frontiers in Neuroscience
- Prognostic factors in ALS: A critical review
- (2009) Adriano Chiò et al. Amyotrophic Lateral Sclerosis
- Nerve Injection of Viral Vectors Efficiently Transfers Transgenes into Motor Neurons and Delivers RNAi Therapy Against ALS
- (2009) Rui Wu et al. ANTIOXIDANTS & REDOX SIGNALING
- Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study
- (2009) A. Alonso et al. EUROPEAN JOURNAL OF NEUROLOGY
- Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice
- (2009) Charlotte J. Sumner et al. HUMAN MOLECULAR GENETICS
- Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
- (2009) Hristelina Ilieva et al. JOURNAL OF CELL BIOLOGY
- TDP-43 is recruited to stress granules in conditions of oxidative insult
- (2009) Claudia Colombrita et al. JOURNAL OF NEUROCHEMISTRY
- Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
- (2009) Sandra Duque et al. MOLECULAR THERAPY
- Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model
- (2009) Bradley J. Turner et al. NEUROBIOLOGY OF DISEASE
- The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis
- (2009) Lijun Wang et al. NEUROBIOLOGY OF DISEASE
- Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
- (2009) C. Vance et al. SCIENCE
- Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
- (2009) T. J. Kwiatkowski et al. SCIENCE
- Alternative Splicing Events Are a Late Feature of Pathology in a Mouse Model of Spinal Muscular Atrophy
- (2009) Dirk Bäumer et al. PLoS Genetics
- Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice
- (2008) Yimin Hua et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Design, power, and interpretation of studies in the standard murine model of ALS
- (2008) Sean Scott et al. Amyotrophic Lateral Sclerosis
- Sustained improvement of spinal muscular atrophy mice treated with trichostatin a plus nutrition
- (2008) Heather L. Narver et al. ANNALS OF NEUROLOGY
- The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response
- (2008) Mattias K Andersson et al. BMC CELL BIOLOGY
- Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice
- (2008) Hidefumi Ito et al. EXPERIMENTAL NEUROLOGY
- Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation
- (2008) Kathrin Meyer et al. HUMAN MOLECULAR GENETICS
- Therapeutic Gene Silencing Delivered by a Chemically Modified Small Interfering RNA against Mutant SOD1 Slows Amyotrophic Lateral Sclerosis Progression
- (2008) Hongyan Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6/1 mice
- (2008) Eileen M. Denovan-Wright et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Direct Muscle Delivery of GDNF With Human Mesenchymal Stem Cells Improves Motor Neuron Survival and Function in a Rat Model of Familial ALS
- (2008) Masatoshi Suzuki et al. MOLECULAR THERAPY
- Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity
- (2008) James C Dodge et al. MOLECULAR THERAPY
- Transient Immunomodulation Allows Repeated Injections of AAV1 and Correction of Muscular Dystrophy in Multiple Muscles
- (2008) Stéphanie Lorain et al. MOLECULAR THERAPY
- Systemic AAV6 Delivery Mediating RNA Interference Against SOD1: Neuromuscular Transduction Does Not Alter Disease Progression in fALS Mice
- (2008) Chris Towne et al. MOLECULAR THERAPY
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
- (2008) Koji Yamanaka et al. NATURE NEUROSCIENCE
- Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS
- (2008) Colin K. Franz et al. NEUROBIOLOGY OF DISEASE
- TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
- (2008) J. Sreedharan et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now